Skip to main content
SpringerLink
Log in

Acute Visual Field Impairment

  • Chapter
  • First Online:
Ocular Emergency

Part of the book series: Ocular Trauma ((OCTRA))

  • 922 Accesses

Abstract

Acute visual field loss is a clinical sign that is frequently encountered in the emergency room. The visual field loss could be caused by a variety of ocular as well as neurological disease processes. Successful diagnosis of visual field loss cases requires careful differential analysis of a wide variety of possibilities, complete examinations of medical and ocular history, and comprehensive ophthalmic examinations. Ancillary tests play a major role in assisting the correct diagnosis of these diseases. Major causes of acute visual field loss are discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995;120:776–83.

    Article  CAS  PubMed  Google Scholar 

  2. Sanborn GE, Magargal LE. Arterial obstructive disease of the eye. In: Tasman WS, Jaegar EA, editors. Clinical ophthalmology, vol. 3 and 14. Philadelphia: Lippincott; 1993. p. 1–29.

    Google Scholar 

  3. Brown GC. Retinal arterial obstructive disease. In: Schachat AP, Murphy RB, Patz A, Ryan SJ, editors. Retina: vol 2 Medical retina. 73rd ed. St Louis: CV Mosby; 1989. p. 1361–77.

    Google Scholar 

  4. Arruga J, Sanders MD. Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology. 1982;89:1336–47.

    Article  CAS  PubMed  Google Scholar 

  5. Lewis JM. Multiple retinal occlusions from a left atrial myxoma. Am J Ophthalmol. 1994;117:674–5.

    Article  CAS  PubMed  Google Scholar 

  6. Greven CM, Weaver RG, Owen J, Slusher MM. Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology. 1991;98:33–4.

    Article  CAS  PubMed  Google Scholar 

  7. Nelson ME, Talbot JF, Preston FE. Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency. Graefes Arch Clin Exp Ophthalmol. 1989;227:443–7.

    Article  CAS  PubMed  Google Scholar 

  8. Brown GC, Magargal LE, Shields JA, et al. Retinal artery obstruction in children and young adults. Ophthalmology. 1981;88:18–25.

    Article  CAS  PubMed  Google Scholar 

  9. Gass JDM, Tiedeman J, Thomas MA. Idiopathic recurrent branch retinal arterial occlusions. Ophthalmology. 1986;93:1148–57.

    Article  CAS  PubMed  Google Scholar 

  10. Johnson MW, Thomley ML, Huang SS, Gass JDM. Idiopathic recurrent branch retinal arterial occlusion. Ophthalmology. 1994;101:480–9.

    Article  CAS  PubMed  Google Scholar 

  11. Fineman MS, Savino PJ, Federman JL, Eagle RC. Branch retinal artery occlusion as the initial sign of giant cell arteritis. Am J Ophthalmol. 1996;112:428–30.

    Article  Google Scholar 

  12. Dutton GN, Craig G. Treatment of a retinal embolus by photocoagulation. Br J Ophthalmol. 1988;72:580–1.

    Google Scholar 

  13. Li HK, Dejean BJ, Tand RA. Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome. Ophthalmology. 1996;103:2091–8.

    Article  CAS  PubMed  Google Scholar 

  14. Brown GC, Magargal LE, Sergott R. Acute obstruction of the retinal and choroidal circulations. Ophthalmology. 1986;93:1373–82.

    Article  CAS  PubMed  Google Scholar 

  15. Brown GC, Moffat K, Cruess A, et al. Cilioretinal artery obstruction. Retina. 1983;3:182–7.

    Article  CAS  PubMed  Google Scholar 

  16. Keyser BJ, Duker JS, Brown GC, et al. Combined central retinal vein occlusion and cilioretinal artery occlusion associated with prolonged retinal arterial filling. Am J Ophthalmol. 1994;117:308–13.

    Article  CAS  PubMed  Google Scholar 

  17. Richards RD. Simultaneous occlusion of the central retinal artery and vein. Trans Am Ophthalmol Soc. 1979;77:191–209.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Jorizzo PA, Klein ML, Shults WT, Linn ML. Visual recovery in combined central retinal artery and central retinal vein occlusion. Am J Ophthalmol. 1987;104:358–63.

    Article  CAS  PubMed  Google Scholar 

  19. Duker JS, Cohen MS, Brown GC, et al. Combined branch retinal artery and central retinal vein obstruction. Retina. 1990;10:105–12.

    Article  CAS  PubMed  Google Scholar 

  20. Duker JS, Brown GL. Anterior location of the crossing artery in branch retinal vein occlusion. Arch Ophthalmol. 1989;107:998–1000.

    Article  CAS  PubMed  Google Scholar 

  21. Spaide RF, Lee JK, Klancnik JK, et al. Optical coherence tomography of branch retinal vein occlusion. Retina. 2003;23:343–7.

    Article  PubMed  Google Scholar 

  22. The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286–96.

    Article  Google Scholar 

  23. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100:1132–40.

    Article  CAS  PubMed  Google Scholar 

  24. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol. 1986;104:34–41.

    Article  Google Scholar 

  25. Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 1986;93:975–7.

    Article  CAS  PubMed  Google Scholar 

  26. Esrick E, Subramanian ML, Heier JS, et al. Multiple laser treatments for macular edema attributable to branch retinal vein occlusion. Am J Ophthalmol. 2005;139:653–7.

    Article  PubMed  Google Scholar 

  27. Amirikia A, Sioh IV, Murray TG, et al. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology. 2001;108:372–6.

    Article  CAS  PubMed  Google Scholar 

  28. Glacet-Bernard A, Coscas G, Chabanel A, et al. Prognostic factors for retinal vein occlusion. A prospective study of 175 cases. Ophthalmology. 1996;103:551–60.

    Article  CAS  PubMed  Google Scholar 

  29. Cekic O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina. 2005;25:851–5.

    Article  PubMed  Google Scholar 

  30. Chen SD, Sundaram V, Lochhead J, et al. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2006;141:876–83.

    Article  CAS  PubMed  Google Scholar 

  31. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244:309–15.

    Article  CAS  PubMed  Google Scholar 

  32. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256–61.

    Article  CAS  PubMed  Google Scholar 

  33. Ostelah MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol. 1998;106:1469–71.

    Google Scholar 

  34. Lakhanpal RR, Javaheri M, Ruiz-Garcia H, et al. Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation. Retina. 2005;25:343–7.

    Article  Google Scholar 

  35. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina. 2004;24:348–55.

    Article  PubMed  Google Scholar 

  36. Tsujikawa A, Fujihara M, Iwawaki T, et al. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina. 2005;25:861–7.

    Article  PubMed  Google Scholar 

  37. Beck RW, Cleary PA, Anderson MA, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581–8.

    Article  CAS  PubMed  Google Scholar 

  38. Beck RW, Cleary PA, Backlund JC, et al. The course of visual recovery after optic neuritis: experience of the Optic Neuritis Treatment Trial. Ophthalmology. 1994;101:1771–8.

    Article  CAS  PubMed  Google Scholar 

  39. Optic Neuritis Study Group. The clinical profile of acute optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673–8.

    Article  Google Scholar 

  40. Arnold AC. Visual field defects in the optic neuritis treatment trial: central vs. peripheral, focal vs. global. Am J Ophthalmol. 1999;128:632–4.

    Article  CAS  PubMed  Google Scholar 

  41. Beck RW, Kupersmith MJ, Cleary PA, et al. Fellow eye abnormalities in acute unilateral optic neuritis: experience of the optic neuritis treatment trial. Ophthalmology. 1993;100:691–8.

    Article  CAS  PubMed  Google Scholar 

  42. Beck RW, Cleary PA. The optic neuritis study group: optic neuritis treatment trial: one-year follow-up results. Arch Ophthalmol. 1993;111:773–5.

    Article  CAS  PubMed  Google Scholar 

  43. Beck RW. The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol. 1995;113:136–7.

    Article  CAS  PubMed  Google Scholar 

  44. Optic Neuritis Study Group. Visual function 5 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 1997;115:1545–52.

    Article  Google Scholar 

  45. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993;329:1764–9.

    Article  CAS  PubMed  Google Scholar 

  46. Optic Neuritis Study Group. The 5-year risk of multiple sclerosis after optic neuritis: experience of the optic neuritis treatment trial. Neurology. 1997;49:1404–13.

    Article  Google Scholar 

  47. Beck RW, Arrington J, Murtagh FR, et al. Brain MRI in acute optic neuritis: experience of the optic neuritis study group. Arch Neurol. 1993;8:841–6.

    Article  Google Scholar 

  48. Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis: results from the optic neuritis treatment trial. J Neuroophthalmol. 1997;17:18–28.

    Article  CAS  PubMed  Google Scholar 

  49. Cole SR, Beck RW, Moke PS, et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Invest Ophthalmol Vis Sci. 2000;41:1017–21.

    CAS  PubMed  Google Scholar 

  50. Trobe JD, Sieving PC, Guire KE, et al. The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology. 1999;106:2047–53.

    Article  CAS  PubMed  Google Scholar 

  51. Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol. 2004;137:77–83.

    Article  Google Scholar 

  52. Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003;121:944–9.

    Article  Google Scholar 

  53. Kaufman DI, Trobe JD, Eggenberger ER, et al. Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Neurology. 2000;54:2039–44.

    Article  CAS  PubMed  Google Scholar 

  54. Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45:244–50.

    Article  CAS  PubMed  Google Scholar 

  55. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–85.

    Article  CAS  PubMed  Google Scholar 

  56. Ulrich J, Groebke-Lorenz W. The optic nerve in multiple sclerosis: a morphological study with retrospective clinico-pathological correlations. Neuro-ophthalmol. 1983;3:149–59.

    Article  Google Scholar 

  57. Kurtzke JF. Optic neuritis or multiple sclerosis. Arch Neurol. 1985;42:704–10.

    Article  CAS  PubMed  Google Scholar 

  58. Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol. 2005;139:1101–11008.

    Article  PubMed  Google Scholar 

  59. Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005;4:111–21.

    Article  PubMed  Google Scholar 

  60. Balcer LJ, Galetta SL. Optic neuritis. In: Rakel RE, Bope ET, editors. Conn’s current therapy. Philadelphia: W.B. Saunders; 2004. p. 187–90.

    Google Scholar 

  61. Foroozan R, Buono LM, Savino PJ, et al. Acute demyelinating optic neuritis. Curr Opin Ophthalmol. 2002;13:375–80.

    Article  PubMed  Google Scholar 

  62. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625–32.

    Article  Google Scholar 

  63. Newman NJ, Biousse V. Hereditary optic neuropathies. Eyes. 2004;18:1144–60.

    CAS  Google Scholar 

  64. Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol. 1995;15:9–10.

    Article  CAS  PubMed  Google Scholar 

  65. Balcer LJ. Optic neuritis. N Engl J Med. 2006;354:1273–80.

    Article  CAS  PubMed  Google Scholar 

  66. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in multiple sclerosis patients. Neurology. 2005;64:992–5.

    Article  CAS  PubMed  Google Scholar 

  67. Balcer LJ, Galetta SL. Optic neuropathies. In: Noseworthy JH, editor. Neurological therapeutics: principles and practice. London: Martin Dunitz; 2003. p. 1709–29.

    Google Scholar 

  68. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963–9.

    Article  PubMed  Google Scholar 

  69. Ray S, Gragoudas E. Neuroretinitis. Int Ophthalmol Clin. 2001;41:83–102.

    Article  CAS  PubMed  Google Scholar 

  70. Hassenstein A, Bialasiewicz AA, Knospe V, et al. Incidence of ocular manifestations in patients with histologically confirmed systemic sarcoidosis [in German]. Klinische Monatsblatter fur Augenheilkunde. 2003;220:414–7.

    Article  PubMed  Google Scholar 

  71. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003;290:1510–4.

    Article  CAS  PubMed  Google Scholar 

  72. Balcer LJ, Winterkorn JMS, Galetta SL. Neuro-ophthalmic manifestations of Lyme disease. J Neuroophthalmol. 1997;17:108–21.

    Article  CAS  PubMed  Google Scholar 

  73. Steere AC. Lyme disease. N Engl J Med. 2001;345:115–25.

    Article  CAS  PubMed  Google Scholar 

  74. Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis. 2003;3:489–500.

    Article  PubMed  Google Scholar 

  75. Suhler EB, Lauer AK, Rosenbaum JT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology. 2000;107:871–6.

    Article  CAS  PubMed  Google Scholar 

  76. Reed JB, Scales DK, Wong MT, et al. Bartonella henselae neuroretinitis in cat scratch disease: diagnosis, management, and sequelae. Ophthalmology. 1998;105:459–66.

    Article  CAS  PubMed  Google Scholar 

  77. Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol. 2000;130:340–9.

    Article  CAS  PubMed  Google Scholar 

  78. Atmaca L, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48:386–91.

    Article  PubMed  Google Scholar 

  79. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 1993;77:371–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Lee AG, Tang RA, Roberts D, et al. Primary central nervous system lymphoma involving the optic chiasm in AIDS. J Neuroophthalmol. 2001;21:95–8.

    Article  PubMed  Google Scholar 

  81. Frohman LP, Frieman BJ, Wolansky L. Reversible blindness resulting from optic chiasmatis secondary to systemic lupus erythematosus. J Neuroophthalmol. 2001;21:18–21.

    Article  CAS  PubMed  Google Scholar 

  82. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon β-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898–904.

    Article  CAS  PubMed  Google Scholar 

  83. Lucchinetti CF, Kiers L, O’Duffy A, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997;49:1413–8.

    Article  CAS  PubMed  Google Scholar 

  84. CHAMPS Study Group. Interferon β-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol. 2001;132:463–71.

    Article  Google Scholar 

  85. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet. 2001;357:1576–82.

    Article  CAS  PubMed  Google Scholar 

  86. Kappos L, Polman C, Freedman MS, et al. Betaferon in newly emerging multiple sclerosis for initial treatment: clinical results. Presented at the 21st Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS), Thessaloniki, Greece, 28 September–1 October, 2005. http://www.akm.ch/ECTRIMS2005. Accessed 24 Feb 2006

    Google Scholar 

  87. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol. 1990;27:12–7.

    Article  CAS  PubMed  Google Scholar 

  88. van Engelen BG, Mommes OR, Pinckers A, et al. Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis [Letter]. Ann Neurol. 1992;32:834–5.

    Article  PubMed  Google Scholar 

  89. Noseworthy JH, O’Brien PC, Petterson TM, et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology. 2001;56:1514–22.

    Article  CAS  PubMed  Google Scholar 

  90. Roed HG, Langkilde A, Sellebjerg F, et al. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology. 2005;64:804–10.

    Article  CAS  PubMed  Google Scholar 

  91. Rolak LA, Beck RW, Paty DW, et al. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology. 1996;46:368–72.

    Article  CAS  PubMed  Google Scholar 

  92. CHAMPIONS Study Group. IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology. 2006;66:678–84.

    Article  CAS  Google Scholar 

  93. Liu GT. Visual loss: optic neuropathies. In: Liu GT, Volpe NJ, Galetta SL, editors. Neuro-ophthalmology: diagnosis and management. Philadelphia: WB Saunders; 2001. p. 103–87.

    Google Scholar 

  94. Scholl GB, Song HS, Wray SH. Uhthoff’s symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis. Ann Neurol. 1991;30:180–4.

    Article  CAS  PubMed  Google Scholar 

  95. Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin North Am. 2001;14:83–98.

    CAS  PubMed  Google Scholar 

  96. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy: population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994;14:38–44.

    Article  CAS  PubMed  Google Scholar 

  97. Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103–7.

    Article  CAS  PubMed  Google Scholar 

  98. MacMichael IM, Cullen JF. Pathology of ischaemic optic neuropathy. In: Cant JS, editor. The optic nerve. Proceedings of the second William MacKenzie memorial symposium. London: Henry Kimpton; 1972. p. 108–16.

    Google Scholar 

  99. Hayreh SS. Anterior ischemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. Eye. 1990;4:25–41.

    Article  PubMed  Google Scholar 

  100. Mack HG, O’Day J, Currie JN. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol. 1991;11:221–7.

    CAS  PubMed  Google Scholar 

  101. Siatkowski RM, Gass JDM, Glaser JS, et al. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol. 1993;115:57–63.

    Article  CAS  PubMed  Google Scholar 

  102. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol. 2003;23:157–63.

    Article  Google Scholar 

  103. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Hayreh SS, Zimmerman BM, Podhajsky PA, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603–24.

    Article  CAS  PubMed  Google Scholar 

  105. Arnold AC, Hepler RS. Fluorescein angiography in acute anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;117:222–30.

    Article  CAS  PubMed  Google Scholar 

  106. Arnold AC, Badr M, Hepler RS. Fluorescein angiography in nonischemic optic disk edema. Arch Ophthalmol. 1996;114:293–8.

    Article  CAS  PubMed  Google Scholar 

  107. Hayreh SS. Anterior ischemic optic neuropathy. V. optic disk edema an early sign. Arch Ophthalmol. 1981;99:1030–40.

    Article  CAS  PubMed  Google Scholar 

  108. Hayreh SS, Podhajsky PA, Zimmerman P. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125:509–20.

    Article  CAS  PubMed  Google Scholar 

  109. Beck RW, Servais GE, Hayreh SS. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology. 1987;94:1503–8.

    Article  CAS  PubMed  Google Scholar 

  110. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 1994;14:66–9.

    Article  CAS  PubMed  Google Scholar 

  111. Yee RD, Selky AK, Purvin VA. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol. 1994;14:70–6.

    CAS  PubMed  Google Scholar 

  112. Beck RW, Hayreh SS, Podhajsky PA, et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:212–7.

    Article  CAS  PubMed  Google Scholar 

  113. Keltner JL. Giant cell arteritis. Signs and symptoms. Ophthalmology. 1982;89:1101–10.

    Article  CAS  PubMed  Google Scholar 

  114. Hayreh SS, Podhajksy PA, Raman R, et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123:285–96.

    Article  CAS  PubMed  Google Scholar 

  115. Boyev LR, Miller NR, Gree WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.

    Article  CAS  PubMed  Google Scholar 

  116. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366–74.

    Article  Google Scholar 

  117. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478–83.

    Article  CAS  PubMed  Google Scholar 

  118. Arnold AC, Hepler RS, Hamilton DR, Lufkin RB. Magnetic resonance imaging of the brain in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 1995;15:158–60.

    CAS  PubMed  Google Scholar 

  119. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766–80.

    Article  CAS  PubMed  Google Scholar 

  120. Pianka P, Almog Y, Man O, et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588–92.

    Article  CAS  PubMed  Google Scholar 

  121. Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999;106:739–42.

    Article  CAS  PubMed  Google Scholar 

  122. Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;122:535–41.

    Article  CAS  PubMed  Google Scholar 

  123. Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve visual loss in recent-onset nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521–6.

    Article  CAS  PubMed  Google Scholar 

  124. Beck RW, Ferris FL. Does levodopa improve visual function in NAION? Ophthalmology. 2000;107:1431–4.

    Article  CAS  PubMed  Google Scholar 

  125. Salomon O, Huna-Baron R, Steinberg DM, et al. Role of aspirin in reducing the frequency of second eye involvement in patients with nonarteritic anterior ischemic optic neuropathy. Eye. 1999;13:357–9.

    Article  PubMed  Google Scholar 

  126. Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with nonarteritic anterior ischemic optic neuropathy [Letter]. Eye. 2000;14:118.

    Article  PubMed  Google Scholar 

  127. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Ophthalmology. 1994;101:1779–85.

    Article  CAS  PubMed  Google Scholar 

  128. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94:1020–8.

    Article  CAS  PubMed  Google Scholar 

  129. Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–5.

    Article  CAS  PubMed  Google Scholar 

  130. Dunker S, Hsu HY, Sebag J, Sadun AA. Perioperative risk factors for posterior ischemic optic neuropathy. J Am Coll Surg. 2002;194:705–10.

    Article  PubMed  Google Scholar 

  131. Sadda SR, Nee M, Miller NR, et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:743–50.

    Article  CAS  PubMed  Google Scholar 

  132. Horton JC. Mistaken treatment of anterior ischemic optic neuropathy with interferon beta-1a. Ann Neurol. 2002;52:129.

    Article  PubMed  Google Scholar 

  133. Hayreh SS, Zahoruk RM. Anterior ischemic optic neuropathy. VI. In juvenile diabetics. Ophthalmologica. 1981;182:13–28.

    Article  CAS  PubMed  Google Scholar 

  134. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995;113:889–95.

    Article  CAS  PubMed  Google Scholar 

  135. Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes. Clinical profile and natural history of 12 cases. Arch Ophthalmol. 1980;98:2185–92.

    Article  CAS  PubMed  Google Scholar 

  136. Kline LB, Morawetz RB, Swaid SN. Indirect injury to the optic nerve. Neurosurgery. 1984;14:756–64.

    Article  CAS  PubMed  Google Scholar 

  137. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy. Surv Opthalmol. 1994;38:487–518.

    Article  CAS  Google Scholar 

  138. Anderson RL, Panje WR, Gross CE. Optic nerve blindness following blunt forehead trauma. Ophthalmology. 1982;89:445–55.

    Article  CAS  PubMed  Google Scholar 

  139. Hupp SL, Buckley EG, Byrne SF, et al. Posttraumatic venous obstructive retinopathy associated with an enlarged optic nerve sheath. Arch Opthalmol. 1984;102:254–6.

    Article  CAS  Google Scholar 

  140. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med. 1990;322:1405–11.

    Article  CAS  PubMed  Google Scholar 

  141. Braughler JM, Hall ED, Means ED, et al. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg. 1987;67:102–5.

    Article  CAS  PubMed  Google Scholar 

  142. Miller NR. The management of traumatic optic neuropathy [Editorial]. Arch Ophthalmol. 1990;108:1086–7.

    Article  CAS  PubMed  Google Scholar 

  143. Warner JE, Lessell S. Traumatic optic neuropathy. Int Ophthalmol Clin. 1995;35:57–62.

    Article  CAS  PubMed  Google Scholar 

  144. Joseph MP, Lessell S, Rizzo J, Momose KJ. Extracranial optic canal decompression for traumatic optic neuropathy. Arch Ophthalmol. 1990;108:1091–3.

    Article  CAS  PubMed  Google Scholar 

  145. Raginiganth MG, Gupta AK, Gupta A, Bapuraj JR. Traumatic optic neuropathy: visual outcome following combined therapy protocol. Arch Otolarygol. 2003;129:1203–6.

    Article  Google Scholar 

  146. Spoor TC, Hartell WC, Lensink DB, et al. Management of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol. 1990;110:665–9.

    Article  CAS  PubMed  Google Scholar 

  147. Levin LA, Beck RW, Joseph MP, et al. The treatment of traumatic optic neuropathy: the international optic nerve study. Ophthalmology. 1999;106:1268–77.

    Article  CAS  PubMed  Google Scholar 

  148. Lee AG. Traumatic optic neuropathy. Ophthalmology. 2000;107:814.

    Article  CAS  PubMed  Google Scholar 

  149. Steinsapir KD. The treatment of traumatic optic neuropathy with high-dose corticosteroids. J Neuroophthalmol. 2006;26:65–7.

    Article  PubMed  Google Scholar 

  150. Eisner G. Biomicroscopy of the peripheral fundus: an atlas and textbook. New York: Springer-Verlag; 1993. p. 45.

    Google Scholar 

  151. Rosengren B, Osterlin S. Hydrodynamic effects in the vitreous space accompanying eye movements: significance for the pathogenesis of retinal detachment. Ophthalmologica. 1976;173:513–24.

    Article  CAS  PubMed  Google Scholar 

  152. Haimann NH, Burton TC, Brown CK. Epidemiology of retinal detachment. Arch Ophthalmol. 1982;100:289–92.

    Article  CAS  PubMed  Google Scholar 

  153. Goldberg MF. Clear lens extraction for axial myopia. An appraisal. Ophthalmology. 1987;94:571–82.

    Article  CAS  PubMed  Google Scholar 

  154. Javitt JC, Street DA, Tielsch JM, et al. Retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology. 1994;101:100–6.

    Article  CAS  PubMed  Google Scholar 

  155. Tielsch JM, Legro MW, Cassard SD, et al. Risk factors for retinal detachment after cataract surgery. A population-based case control study. Ophthalmology. 1996;103:1537–45.

    Article  CAS  PubMed  Google Scholar 

  156. The Eye Disease Case Control Study Group. Risk factors for idiopathic rhegmatogenous retinal detachment. Am J Ophthalmol. 1993;137:749–57.

    Google Scholar 

  157. Brod RD, Flynn HW, Lightman DA. Asymptomatic rhegmatogenous retinal detachments. Arch Ophthalmol. 1995;113:1030–2.

    Article  CAS  PubMed  Google Scholar 

  158. Lincoff H, Geiser R. Finding the retinal hole. Arch Ophthalmol. 1971;85:565–9.

    Article  CAS  PubMed  Google Scholar 

  159. Kroll AJ, Machemer R. Experimental retinal detachment in the owl monkey. III. Electron microscopy of the retina and pigment epithelium. Am J Ophthalmol. 1968;66:410–27.

    Article  CAS  PubMed  Google Scholar 

  160. Green WR. Retina. In: Spencer WH, editor. Ophthalmic pathology. An atlas and textbook. 4th ed. Philadelphia: WB Saunders; 1996. p. 961–4.

    Google Scholar 

  161. Wilson DJ, Green WR. Histopathologic study of the effect of retinal detachment on 49 eyes obtained post mortem. Am J Ophthalmol. 1987;103:167–79.

    Article  CAS  PubMed  Google Scholar 

  162. Brinton DA, Lit ES. Pneumatic retinopexy. In: Ryan SJ, Wilkinson CP, editors. Retina. 4th ed. Philadelphia: Mosby; 2006. p. 2071–83.

    Chapter  Google Scholar 

  163. Wilkinson CP. Visual results following scleral buckling for retinal detachments sparing the macula. Retina. 1981;1:113–6.

    Article  CAS  PubMed  Google Scholar 

  164. Burton TC. Recovery of visual acuity after retinal detachment involving the macula. Trans Am Ophthalmol Soc. 1982;80:475–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  165. Greven CM, Sanders RJ, Brown GC, et al. Pseudophakic retinal detachments. Anatomic and visual results. Ophthalmology. 1992;99:257–62.

    Article  CAS  PubMed  Google Scholar 

  166. Hunt JR. On herpetic inflammations of the geniculate ganglion. A new syndrome and its implications. J Nerve Ment Dis. 1907;34:73.

    Article  Google Scholar 

  167. Hunt JR. A further contribution to herpetic inflammations of the geniculate ganglion. Am J Med Sci. 1916;136:226.

    Article  Google Scholar 

  168. Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia. Clinical review and current management. Ann Neurol. 1986;20:651.

    Article  CAS  PubMed  Google Scholar 

  169. Stafford FW, Welch AR. The use of acyclovir in Ramsay Hunt syndrome. J Laryngol Otol. 1986;100:337.

    Article  CAS  PubMed  Google Scholar 

  170. Inamura H, Aoyagi M, Tojima H, Koike Y. Effects of acyclovir in Ramsay Hunt syndrome. Acta Otolaryngol. 1988;446(suppl):111.

    CAS  Google Scholar 

  171. Kinishi M, Amatsu M, Mohri M, et al. Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Ausis, Nasus, Larynx. 2001;28(3):223.

    Article  CAS  Google Scholar 

  172. Abramsky O, Webb C, Tietelbaum D. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell’s palsy). J Neurol Sci. 1975;26:13.

    Article  CAS  PubMed  Google Scholar 

  173. Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol. 1981;9(suppl):1.

    Article  PubMed  Google Scholar 

  174. Ohtsuka K, Nakamura Y, Hashimoto M, et al. Fisher syndrome associated with IgG antiGQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology. 1998;105:1281.

    Article  CAS  PubMed  Google Scholar 

  175. Charous DI, Saxe BI. Landry-Guillain-Barré syndrome: report of an unusual case with a comment on Bell’s palsy. N Engl J Med. 1962;267:1334.

    Article  CAS  PubMed  Google Scholar 

  176. Clark JR, Carlson RD, Sasak CT. Facial paralysis in Lyme disease. Laryngoscope. 1985;95:1341.

    CAS  PubMed  Google Scholar 

  177. Peltomaa M, Pyykko I, Seppala I, et al. Lyme borreliosis and facial paralysis-a prospective analysis of risk factors and outcome. Am J Otolaryngol. 2002;23(3):125.

    Article  PubMed  Google Scholar 

  178. Markby DP. Lyme disease facial palsy: Differentiation from Bell’s palsy. Br Med J. 1989;299:605.

    Article  CAS  Google Scholar 

  179. Rawlings JA, Fournier PU, Teltow GJ. Isolation of Borrelia spirochetes from patients in Texas. J Clin Microbiol. 1987;25:1148.

    CAS  PubMed  PubMed Central  Google Scholar 

  180. Hunter EF, Russel H, Farstly CE. Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis. Sex Transm Dis. 1986;13:232.

    Article  CAS  PubMed  Google Scholar 

  181. Kamitsuka M, Feldman R, Richardson M. Facial paralysis associated with otitis media. Pediatr Infect Dis. 1985;6:682.

    Article  Google Scholar 

  182. Yetiser S, Tosun F, Kazkayasi M, et al. Facial nerve paralysis due to chronic otitis media. Otol Neurotol. 2002;23:580.

    Article  PubMed  Google Scholar 

  183. Gradenigo G. A special syndrome of endocranial otitic complications. Ann Otol Rhinol Laryngol. 1904;13:637.

    Article  Google Scholar 

  184. Kohut RF, Lindsay JR. Necrotizing (malignant) external otitis histopathologic processes. Ann Otol. 1979;88:714.

    CAS  Google Scholar 

  185. Naldol JB. Histopathology of pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol. 1980;115:359.

    Article  Google Scholar 

  186. McGove FH. Bilateral Bell’s palsy. Laryngoscope. 1965;75:1070.

    Google Scholar 

  187. Dreifus FE, Martin JD, Green RC. Brainstem encephalitis. Va Med Month. 1964;91:15.

    Google Scholar 

  188. Yasui I, Miyasaki T. Case of poliomyelitis due to virus type I manifested only by right facial paralysis. J Jpn Assn Infect Dis. 1962;36:427.

    CAS  Google Scholar 

  189. Sklar VEF, Patriarca PA, Onorato IM. Clinical findings and results of treatment in an outbreak of acute hemorrhagic conjunctivitis is southern Florida. Ain J Ophthalmol. 1983;95:45.

    Article  CAS  Google Scholar 

  190. Bosher SK. Leprosy presenting as facial palsy. J Laryngol. 1962;76:827.

    Article  CAS  Google Scholar 

  191. Lucente FE, Tobias GW, Parisier SC. Tuberculous otitis media. Laryngoscope. 1978;88:1107.

    Article  CAS  PubMed  Google Scholar 

  192. Bergstrom L, Hemenway WG, Barnhardt RA. Rhinocerebral and otologic mucormycosis. Ann Otol. 1970;79:70.

    CAS  Google Scholar 

  193. Gussen R, Canalis RF. Mucormycosis of the temporal bone. Ann Otol. 1982;91:27.

    CAS  Google Scholar 

  194. Verduijn PG, Bleeker JD. Secondary syphilis of the facial nerve. Arch Otolaryngol. 1939;48:675.

    Google Scholar 

  195. Dastur FD, Shahani MT, Dastoor DH, et al. Cephalic tetanus: demonstration of a dual lesion. J Neurol Neurosurg Psychiatry. 1977;40:782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  196. Harrison TR. Principles of internal medicine. 12th ed. New York: McGraw-Hill; 1987.

    Google Scholar 

  197. Thompson PK, Vaphiades MS, Saccente M, et al. Cat scratch disease presenting as neuroretinitis and peripheral facial palsy. J Neuro-Ophthalmology. 1999;19:240.

    Article  CAS  Google Scholar 

  198. Grant AC, Hunter S, Partin WC. A case of acute monocytic ehrlichiosis with prominent neurologic signs. Neurology. 1997;48:1619.

    Article  CAS  PubMed  Google Scholar 

  199. Sahludovich S. Accidents due to antirabies vaccine: pseudoperitoneal syndrome followed by bilateral paralysis: case. Ed Dia Medico (Buenos Aires). 1946;18:1454.

    Google Scholar 

  200. Jappich G. Effects and side effects of oral poliomyelitis vaccinations. Monatsschr Kinderheilkd. 1964;112:112.

    Google Scholar 

  201. Danforth HB. Familial Bell’s palsy. Ann Otol. 1964;73:179.

    CAS  Google Scholar 

  202. Lerond J. Ascending paralysis after tetanus antiserum’s rapid regression in member lingering facial paralysis. Bull Mem Soc Med Hop Paris. 1926;50:1695.

    Google Scholar 

  203. Wechsler AF, Ho DD. Bilateral Bell’s palsy at the time of HIV seroconversion. Neurology. 1989;39:747.

    Article  CAS  PubMed  Google Scholar 

  204. Keane J. Neuro-ophthalmologic signs of AIDS: 50 patients. Neurology. 1991;41:841.

    Article  CAS  PubMed  Google Scholar 

  205. Nichols JW, Goodwin JA. Neuro-ophthalmologic complications of AIDS. Semin Ophthalmol. 1992;7:24.

    Article  Google Scholar 

  206. Tenhula WN, SZ X, Madigan MC, et al. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:14.

    Article  CAS  PubMed  Google Scholar 

  207. Patel SS, Rutzen AR, Marx JL, et al. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1996;103:1476.

    Article  CAS  PubMed  Google Scholar 

  208. Cohen DB, Glasgow BJ. Bilateral optic nerve cryptococcosis in sudden blindness in patients with acquired immune deficiency syndrome. Ophthalmology. 1993;100:1689.

    Article  CAS  PubMed  Google Scholar 

  209. Garrity JA, Herman DC, Imes R, et al. Optic nerve sheath decompression for visual loss in patients with acquired immunodeficiency syndrome and cryptococcal meningitis with papilledema. Am J Ophthalmol. 1993;116:472.

    Article  CAS  PubMed  Google Scholar 

  210. Grossniklaus HE, Specht CS, Allaire G, et al. Toxoplasma gondii retinochoroiditis and optic neuritis in acquired immune deficiency syndrome: report of a case. Ophthalmology. 1990;97:1342.

    Article  CAS  PubMed  Google Scholar 

  211. Shayegani A, Odel JG, Kazim M, et al. Varicella-zoster virus optic neuritis in a patient with human immunodeficiency virus. Am J Ophthalmol. 1996;122:586.

    Article  CAS  PubMed  Google Scholar 

  212. Lee MS, Cooney EL, Stoessel KM, et al. Varicella zoster virus retrobulbar optic neuritis in patients with acquired immunodeficiency syndrome. Ophthalmology. 1998;105:467.

    Article  CAS  PubMed  Google Scholar 

  213. Yau TH. Rivera-Velazquez, Mark AS et al: Unilateral optic neuritis in a patient with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;121:324.

    Article  CAS  PubMed  Google Scholar 

  214. Gabuzda DH, Hirsch MS. Neurologic manifestations of infection with human immunodeficiency virus. Ann Intern Med. 1987;107:383.

    Article  CAS  PubMed  Google Scholar 

  215. Burton BJL, Leff AP. Plant steroid-responsive HIV optic neuropathy. J Neuroophthalmol. 1998;18:25.

    Article  CAS  PubMed  Google Scholar 

  216. Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol. 1992;37:203.

    Article  CAS  PubMed  Google Scholar 

  217. Zambrano W, Perez GM, Smith JL. Acute syphilitic blindness in AIDS. J Clin Neuroophthalmol. 1987;7:1.

    Article  CAS  PubMed  Google Scholar 

  218. Toshniwal P. Optic perineuritis with secondary syphilis. J Clin Neuroophthalmol. 1987;7:6.

    CAS  PubMed  Google Scholar 

  219. Arruga J, Valentines J, Mauri F, et al. Neuroretinitis in acquired syphilis. Ophthalmology. 1985;92:262.

    Article  CAS  PubMed  Google Scholar 

  220. Balcer LJ, Winterkorn JMS, Galetta SL. Neuro-ophthalmic manifestations of Lyme disease. J Neuroophthalmol. 1997;17:108.

    Article  CAS  PubMed  Google Scholar 

  221. Schmutzhard E, Pohl P, Stanek G. Involvement of Borrelia burgdorferi in cranial nerve affection. Zentrabl Bakt Hyg A. 1986;263:328.

    Google Scholar 

  222. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985;35:47.

    Article  CAS  PubMed  Google Scholar 

  223. Wu G, Lincoff H, Ellsworth RM, et al. Optic disc edema and Lyme disease. Ann Ophthalmol. 1986;18:252.

    CAS  PubMed  Google Scholar 

  224. Strominger MB, Slamovits TL, Herskovitz S, et al. Transient worsening of optic neuropathy as a sequela of the Jarisch-Herxheimer reaction in the treatment of Lyme disease. J Neuroophthalmol. 1994;14:77.

    Article  CAS  PubMed  Google Scholar 

  225. Lyme disease. Connecticut. JAMA. 1988;259:1147.

    Article  Google Scholar 

  226. Wong MT, Dolan MJ, Lattuada CP, et al. Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis. 1995;21:352.

    Article  CAS  PubMed  Google Scholar 

  227. Golnik KC, Marotto ME, Fanous MM, et al. Ophthalmic manifestations of Rochalimaea species. Am J Ophthalmol. 1994;118:145.

    Article  CAS  PubMed  Google Scholar 

  228. Cox TA, Haskins GE, Gangitano JL, et al. Bilateral Toxocara optic neuropathy. J Clin Neuroophthalmol. 1983;3:267.

    CAS  PubMed  Google Scholar 

  229. Fish RH, Hoskins JC, Kline LB. Toxoplasmosis neuroretinitis. Ophthalmology. 1993;100:1177.

    Article  CAS  PubMed  Google Scholar 

  230. Lossos A, Eliashiv S, Ben-Chetrit E. Optic neuritis associated with familial Mediterranean fever. J Clin Neuroophthalmol. 1993;13:141.

    CAS  PubMed  Google Scholar 

  231. Hedstrom J, Parsons J, Maloney PL, Doku HC. Superior orbital fissure syndrome: report of case. J Oral Surg. 1974;32(3):198–201.

    CAS  PubMed  Google Scholar 

  232. Hardt N, Sgier F. Results of surgical intervention in traumatic orbital syndromes. In:Fortschr Kiefer Gesichts Chir, vol. 36. Stuttgart/New York: Thieme; 1991. p. 165–7.

    Google Scholar 

  233. Mathog RH, Arden RL, Marks SC. Trauma of the nose and paranasal sinuses. Stuttgart/New York: Thieme; 1995.

    Google Scholar 

  234. Brent BD, May DR. Orbital apex syndrome after penetrating orbital trauma. Ann Ophthalmol. 1990;22(7):267–8.

    CAS  PubMed  Google Scholar 

  235. Radtke J, Zahn W. Acuminate orbit syndrome-complications of upper midfacial fractures. Fortschr Kiefer Gesichtschir. 1991;36:155–7.

    CAS  PubMed  Google Scholar 

  236. Lisch K. Direkte und indirekte Verletzungsfolgen der Sehbahn beim Kopftrauma. In: Ehrich W, Remler O, editors. Das Kopftrauma aus augenärztlicher Sicht. Stuttgart: Enke; 1976. p. 99–107.

    Google Scholar 

  237. Stewart GS, Soparkar CN. Orbital fractures. In: Stewart GS, editor. Head, face, and neck trauma. Stuttgart: Thieme; 2005. p. 59–67.

    Google Scholar 

  238. Soparkar CN. Ophthalmic and optic nerve trauma. In: Stewart GS, editor. Head, face and neck trauma. New York: Thieme; 2005. p. 52–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Mississippi Medical Center, Jackson, 39216, MS, USA

    Bo Huang

  2. Shandong Eye Hospital, Shandong Eye Institute, Qingdao, China

    Suxia Li

Authors
  1. Bo Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suxia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Huang .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China

    Hua Yan

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Huang, B., Li, S. (2018). Acute Visual Field Impairment. In: Yan, H. (eds) Ocular Emergency. Ocular Trauma. Springer, Singapore. https://doi.org/10.1007/978-981-10-6802-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-6802-7_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-6801-0

  • Online ISBN: 978-981-10-6802-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation